Results 11 to 20 of about 73,107 (244)

Sarcoidosis Illuminations on Living During COVID-19: Patient Experiences of Diagnosis, Management, and Survival Before and During the Pandemic

open access: yesJournal of Patient Experience, 2022
Background: Inspired by intense challenges encountered by patients and clinicians, we examined the experiences of living with sarcoidosis in three of the hardest impacted English-speaking cities during the early COVID-19 pandemic: London, New Orleans ...
Lesley Ann Saketkoo MD, MPH   +14 more
doaj   +1 more source

Sarcoidosis lung transplantation waitlist mortality, a national registry database study

open access: yesERJ Open Research, 2023
Background The Lung Allocation Score (LAS) prioritises lung transplantation candidates, balancing waitlist mortality and post-transplant survival. The score groups sarcoidosis candidates based on mean pulmonary artery pressure: those with ≤30 mmHg ...
Derlis C. Fleitas Sosa   +9 more
doaj   +1 more source

Safety and tolerability of pirfenidone in asbestosis: a prospective multicenter study

open access: yesRespiratory Research, 2022
Background Pirfenidone slows down disease progression in idiopathic pulmonary fibrosis (IPF). Recent studies suggest a treatment effect in progressive pulmonary fibrosis other than IPF.
Jelle R. Miedema   +7 more
doaj   +1 more source

The Relationship between Tumor Development and Sarcoidosis in Aspects of Carcinogenesis before and after the Onset of Sarcoidosis

open access: yesMedicina, 2022
Background and Objectives: It is still unclear whether sarcoidosis is likely to be associated with tumors. In addition, the use of an immune checkpoint inhibitor has been reported to initiate the onset of sarcoidosis.
Yoshimasa Hachisu   +11 more
doaj   +1 more source

Design of a randomized controlled trial to evaluate effectiveness of methotrexate versus prednisone as first-line treatment for pulmonary sarcoidosis: the PREDMETH study

open access: yesBMC Pulmonary Medicine, 2020
Background Treatment of pulmonary sarcoidosis is recommended in case of significant symptoms, impaired or deteriorating lung function. Evidence-based treatment recommendations are limited and largely based on expert opinion.
Vivienne Kahlmann   +10 more
doaj   +1 more source

Sarcoidosis of the hypothalamus and pituitary stalk [PDF]

open access: yes, 1992
We report a rare case of sarcoidosis of the hypothalamic and suprasellar region, with clinical course and the magnetic resonance imaging follow ...
Stemmler, J.   +3 more
core   +1 more source

Sarcoidosis [PDF]

open access: yesInternational Ophthalmology Clinics, 1995
Sarcoidosis is a systemic granulomatous process of unknown cause. Pathologically, it is characterized by noncaseous granuloma, and in more than 90% of patients, the lung or intrathoracic lymph nodes are affected. A roentgenographic staging system (stages I, II, and III), based on the appearance of the plain chest roentgenogram, conveys important ...
R M, Stanbury, E M, Graham, P I, Murray
openaire   +4 more sources

Ankylosing spondylitis and sarcoidosis — Coincidence or association? [PDF]

open access: yes, 1992
We report a 25-year-old woman presenting with sarcoidosis and bilateral sacroiliitis. Her sarcoidosis related symptoms (malaise, cough and dyspnoea) improved dramatically under treatment with steroids but severe back pain persisted.
Stucki, Gerold   +3 more
core   +1 more source

Research progress on drug treament for sarcoidosis [PDF]

open access: yesXin yixue, 2023
Sarcoidosis is a systemic disease characterized by non-caseous epithelioid cell granuloma,which can involve with multiple organs,especially the lung. Sarcoidosis is characterized by diverse clinical manifestations and high incidence rate.
Luo Cheng, Wu Cong, Wang Yuguang
doaj   +1 more source

Transcriptional Blood Signatures Distinguish Pulmonary Tuberculosis, Pulmonary Sarcoidosis, Pneumonias and Lung Cancers [PDF]

open access: yes, 2013
Rationale New approaches to define factors underlying the immunopathogenesis of pulmonary diseases including sarcoidosis and tuberculosis are needed to develop new treatments and biomarkers. Comparing the blood transcriptional response of tuberculosis
Lipman, M   +122 more
core   +1 more source

Home - About - Disclaimer - Privacy